New funding could transform patient outcomes
The UK Government has announced funding to support cutting-edge health projects, which could transform patient outcomes.
“From new software to diagnose breast cancer to improved gene therapies for children with leukaemia, these projects show the life-changing effect UK research can have,” said Life Sciences Minister Lord Henley.
The funding has been awarded under the Biomedical Catalyst (BMC) programme jointly run by the UK’s innovation agency, Innovate UK, and the Medical Research Council (MRC), which are both part of UK Research and Innovation.
“Increasingly, new technologies and treatments are able to address debilitating and chronic conditions that are hard to treat. By continuing to invest in innovation through programmes such as the Biomedical Catalyst, we can continue to transform outcomes for patients and support and grow the UK’s world-leading health sector,” said Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK.
Dr Louise Jones, Head of Translational Research at the MRC, said: “These latest projects are further demonstration of the world-leading science coming out of the vibrant academic and industrial research base of the UK. The success of the Catalyst’s funding schemes shows the value of dedicated support in the development of therapies, diagnostics and devices that will benefit both patients and the UK economy.”